Trial Profile
A prospective, single center, double blind, placebo controlled study of adipocytokines, adipose tissue gene expression and hepatic insulin clearance in the therapeutic response to vildagliptin in man.
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 16 Mar 2012
Price :
$35
*
At a glance
- Drugs Metformin (Primary) ; Vildagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Biomarker; Pharmacodynamics; Pharmacogenomic
- 27 Jul 2011 New trial record